Cyclica harnesses AI and machine learning, along with a vast library of global human genome discovery, to model potential protein interactions and drastically speed up the drug discovery process.
PETER POWER/THE GLOBE AND MAIL
AI Drug Discovery Company Cyclica Featured in Globe and Mail
Updated: Nov 4, 2021
Comments